PF-07321332/ritonavir
Sponsors
Pfizer
Conditions
BioavailabilityHealthy ParticipantHealthy ParticipantsRenal Impairment
Phase 1
Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function.
CompletedNCT04909853
Start: 2021-06-15End: 2021-10-07Updated: 2023-08-02
Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants
CompletedNCT04962022
Start: 2021-07-20End: 2021-09-30Updated: 2023-07-13
Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir
CompletedNCT04962230
Start: 2021-07-15End: 2021-10-09Updated: 2023-10-10
Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult Participants
CompletedNCT05129475
Start: 2021-11-12End: 2022-01-12Updated: 2023-10-05
Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation
CompletedNCT05263895
Start: 2022-03-03End: 2022-05-16Updated: 2025-06-11
Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants
CompletedNCT05263921
Start: 2022-03-10End: 2022-05-19Updated: 2024-06-06
A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.
CompletedNCT05339334
Start: 2022-03-10End: 2022-04-21Updated: 2024-10-08